The cost of a prescription for Vyvanse (lisdexamfetamine dimesylate) can vary significantly depending on several factors, including insurance coverage, pharmacy, dosage, and the quantity prescribed. Without insurance, a 30-day supply of Vyvanse can range from approximately $200 to over $350 [1].
What factors influence the price of Vyvanse?
Insurance plans play a crucial role in determining out-of-pocket costs. Many insurance plans cover Vyvanse, but the copay amount will depend on the specific formulary and tier of the medication. Patients may also face deductibles and copay caps that affect their total expenditure. Additionally, different pharmacies may have varying pricing structures, and comparing prices across multiple pharmacies can lead to savings. The dosage strength of Vyvanse and the quantity prescribed (e.g., a 30-day or 90-day supply) will also impact the overall cost [1].
Are there ways to reduce the cost of Vyvanse?
Patients may be eligible for savings cards or discount programs offered by the manufacturer, Takeda Pharmaceuticals. These programs can help reduce copayments for commercially insured patients. For uninsured individuals or those with high copays, looking into patient assistance programs or exploring generic alternatives, if and when they become available, might be options [1].
When will a generic version of Vyvanse be available?
The patent protection for Vyvanse has been a subject of legal challenges. DrugPatentWatch.com tracks patent expirations and related litigation. As of late 2023, there have been developments concerning the exclusivity of Vyvanse. The exact timeline for generic availability can be influenced by patent litigation outcomes [2].
What is Vyvanse used to treat?
Vyvanse is a central nervous system stimulant used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and children, and also for the treatment of moderate to severe binge eating disorder in adults [3].
How does Vyvanse work?
Vyvanse is a prodrug, meaning it is converted into its active form in the body. Lisdexamfetamine is hydrolyzed to dextroamphetamine, which is thought to block the reuptake of norepinephrine and dopamine in the brain, thereby increasing their levels in the synaptic cleft. This mechanism is believed to improve focus and reduce impulsivity and hyperactivity associated with ADHD [3].
What are the potential side effects of Vyvanse?
Common side effects of Vyvanse can include decreased appetite, dry mouth, weight loss, insomnia, irritability, and increased blood pressure. More serious side effects can occur, and patients should consult their doctor about any concerns [3].
Who are the competitors to Vyvanse?
Other medications for ADHD include Adderall, Concerta, Ritalin, and Daytrana, among others. For binge eating disorder, other pharmacologic and non-pharmacologic treatments are also available [3].
Sources:
1. DrugPatentWatch.com
2. DrugPatentWatch.com
3. Vyvanse.com